{"title":"Coptisine上调miR-146a-5p表达,通过PI3K/AKT通路减轻1-甲基-4-苯基啶诱导的帕金森病细胞模型损伤","authors":"Hong-li Chen, Hu-Yi Liang, Yan Li","doi":"10.3760/CMA.J.ISSN.1671-8925.2020.01.001","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the effect of coptisine on 1-methyl-4-phenylpy ridinium(MPP+) induced Parkinson's disease (PD) cell injury and its mechanism. \n \n \nMethods \nSK-N-SH cells were treated with 0.3 mmol/L MPP+ to induce PD cell models (MPP+ group); normal cultured cells were used as blank controls (NCs); pretreatment with coptisine at concentrations of 10, 20, and 40 μmol/L for 4 h was performed after giving 0.3 mmol/L MPP+, different concentration coptisine treatment groups were named. And miR-con and miR-146a-5p were transfected into SK-N-SH cells and treated with 0.3 mmol/L MPP+, and named MPP++miR-con group and MPP++miR-146a-5p group; anti-miR-con and anti-miR-146a-5p were transfected into SK-N-SH cells and pretreated with 20 μmol/L coptisine for 4 h, and then, treated with 0.3 mmol/L MPP+, and named MPP++Cop+anti-miR-con group and MPP++Cop+anti-miR-146a-5p group. Cell viability was determined by MTT assay; Western blotting was used to detect the protein expressions of cleaved cysteine-containing aspartate-specific proteases-3 (caspase-3), CyclinD1, phosphorylated protein kinase B (p-AKT), p-phosphoinositide 3 kinase (p-PI3K); apoptosis was detected by flow cytometry; real-time quantitative PCR (RT-qPCR) was used to detect the miR-146a-5p expression. \n \n \nResults \nAs compared with the NCs, the MPP+ induced SK-N-SH cells had significantly decreased viability and CyclinD1 and miR-146a-5p expressions, and significantly increased cleaved caspase-3 expression and apoptosis rate (P<0.05). After coptisine treatment and miR-146a-5p overexpression, MPP+ induced SK-N-SH cells had significantly increased viability and expressions of CyclinD1 and miR-146a-5p, and significantly decreased cleaved-caspase-3 expression and apoptosis rate (P<0.05). Low expression of miR-146a-5p reversed the effect of coptisine on proliferation promotion and apoptosis inhibition of SK-N-SH cells. The expression levels of p-AKT and p-PI3K in MPP+-induced SK-N-SH cells were significantly increased after coptisine treatment. Low expression of miR-146a-5p reversed the effect of coptisine on expressions of p-AKT and p-PI3K. \n \n \nConclusion \nCoptisine can promote cell survival and inhibit MPP+-induced apoptosis, which may be related to miR-146a-5p and PI3K/AKT signaling pathways. \n \n \nKey words: \nCoptisine; MiR-146a-5p; PI3K/AKT signaling pathway; Parkinson's disease; Cell injury","PeriodicalId":10104,"journal":{"name":"中华神经医学杂志","volume":"36 1","pages":"2-8"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Coptisine up-regulates miR-146a-5p expression to attenuate injury of Parkinson's disease cell models induced by 1-methyl-4-phenylpy ridinium via PI3K/AKT pathway\",\"authors\":\"Hong-li Chen, Hu-Yi Liang, Yan Li\",\"doi\":\"10.3760/CMA.J.ISSN.1671-8925.2020.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the effect of coptisine on 1-methyl-4-phenylpy ridinium(MPP+) induced Parkinson's disease (PD) cell injury and its mechanism. \\n \\n \\nMethods \\nSK-N-SH cells were treated with 0.3 mmol/L MPP+ to induce PD cell models (MPP+ group); normal cultured cells were used as blank controls (NCs); pretreatment with coptisine at concentrations of 10, 20, and 40 μmol/L for 4 h was performed after giving 0.3 mmol/L MPP+, different concentration coptisine treatment groups were named. And miR-con and miR-146a-5p were transfected into SK-N-SH cells and treated with 0.3 mmol/L MPP+, and named MPP++miR-con group and MPP++miR-146a-5p group; anti-miR-con and anti-miR-146a-5p were transfected into SK-N-SH cells and pretreated with 20 μmol/L coptisine for 4 h, and then, treated with 0.3 mmol/L MPP+, and named MPP++Cop+anti-miR-con group and MPP++Cop+anti-miR-146a-5p group. Cell viability was determined by MTT assay; Western blotting was used to detect the protein expressions of cleaved cysteine-containing aspartate-specific proteases-3 (caspase-3), CyclinD1, phosphorylated protein kinase B (p-AKT), p-phosphoinositide 3 kinase (p-PI3K); apoptosis was detected by flow cytometry; real-time quantitative PCR (RT-qPCR) was used to detect the miR-146a-5p expression. \\n \\n \\nResults \\nAs compared with the NCs, the MPP+ induced SK-N-SH cells had significantly decreased viability and CyclinD1 and miR-146a-5p expressions, and significantly increased cleaved caspase-3 expression and apoptosis rate (P<0.05). After coptisine treatment and miR-146a-5p overexpression, MPP+ induced SK-N-SH cells had significantly increased viability and expressions of CyclinD1 and miR-146a-5p, and significantly decreased cleaved-caspase-3 expression and apoptosis rate (P<0.05). Low expression of miR-146a-5p reversed the effect of coptisine on proliferation promotion and apoptosis inhibition of SK-N-SH cells. The expression levels of p-AKT and p-PI3K in MPP+-induced SK-N-SH cells were significantly increased after coptisine treatment. Low expression of miR-146a-5p reversed the effect of coptisine on expressions of p-AKT and p-PI3K. \\n \\n \\nConclusion \\nCoptisine can promote cell survival and inhibit MPP+-induced apoptosis, which may be related to miR-146a-5p and PI3K/AKT signaling pathways. \\n \\n \\nKey words: \\nCoptisine; MiR-146a-5p; PI3K/AKT signaling pathway; Parkinson's disease; Cell injury\",\"PeriodicalId\":10104,\"journal\":{\"name\":\"中华神经医学杂志\",\"volume\":\"36 1\",\"pages\":\"2-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华神经医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1671-8925.2020.01.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华神经医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1671-8925.2020.01.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Coptisine up-regulates miR-146a-5p expression to attenuate injury of Parkinson's disease cell models induced by 1-methyl-4-phenylpy ridinium via PI3K/AKT pathway
Objective
To investigate the effect of coptisine on 1-methyl-4-phenylpy ridinium(MPP+) induced Parkinson's disease (PD) cell injury and its mechanism.
Methods
SK-N-SH cells were treated with 0.3 mmol/L MPP+ to induce PD cell models (MPP+ group); normal cultured cells were used as blank controls (NCs); pretreatment with coptisine at concentrations of 10, 20, and 40 μmol/L for 4 h was performed after giving 0.3 mmol/L MPP+, different concentration coptisine treatment groups were named. And miR-con and miR-146a-5p were transfected into SK-N-SH cells and treated with 0.3 mmol/L MPP+, and named MPP++miR-con group and MPP++miR-146a-5p group; anti-miR-con and anti-miR-146a-5p were transfected into SK-N-SH cells and pretreated with 20 μmol/L coptisine for 4 h, and then, treated with 0.3 mmol/L MPP+, and named MPP++Cop+anti-miR-con group and MPP++Cop+anti-miR-146a-5p group. Cell viability was determined by MTT assay; Western blotting was used to detect the protein expressions of cleaved cysteine-containing aspartate-specific proteases-3 (caspase-3), CyclinD1, phosphorylated protein kinase B (p-AKT), p-phosphoinositide 3 kinase (p-PI3K); apoptosis was detected by flow cytometry; real-time quantitative PCR (RT-qPCR) was used to detect the miR-146a-5p expression.
Results
As compared with the NCs, the MPP+ induced SK-N-SH cells had significantly decreased viability and CyclinD1 and miR-146a-5p expressions, and significantly increased cleaved caspase-3 expression and apoptosis rate (P<0.05). After coptisine treatment and miR-146a-5p overexpression, MPP+ induced SK-N-SH cells had significantly increased viability and expressions of CyclinD1 and miR-146a-5p, and significantly decreased cleaved-caspase-3 expression and apoptosis rate (P<0.05). Low expression of miR-146a-5p reversed the effect of coptisine on proliferation promotion and apoptosis inhibition of SK-N-SH cells. The expression levels of p-AKT and p-PI3K in MPP+-induced SK-N-SH cells were significantly increased after coptisine treatment. Low expression of miR-146a-5p reversed the effect of coptisine on expressions of p-AKT and p-PI3K.
Conclusion
Coptisine can promote cell survival and inhibit MPP+-induced apoptosis, which may be related to miR-146a-5p and PI3K/AKT signaling pathways.
Key words:
Coptisine; MiR-146a-5p; PI3K/AKT signaling pathway; Parkinson's disease; Cell injury